Foundation Medicine
FMI
FMI was delisted on the 30th of July, 2018.
17 hedge funds and large institutions have $47.9M invested in Foundation Medicine in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
4.3% more ownership
Funds ownership: 0% → 4.3% (+4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$19.5M |
| 2 |
Pier Capital
Stamford,
Connecticut
|
+$5.9M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.65M |
| 4 |
Driehaus Capital Management
Chicago,
Illinois
|
+$2.95M |
| 5 |
Frontier Capital Management
Boston,
Massachusetts
|
+$2.73M |
Top Sellers
FMI Hedge Fund Activity: Q3 2013 in Review
17 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine (FMI) for Q3 2013, worth a combined $47.9M.
Buyers outnumbered sellers: 17 funds opened new FMI positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $19.5M.
- 17 institutional investors held Foundation Medicine (FMI) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $47.9M of Foundation Medicine stock for Q3 2013.
- 17 funds opened new Foundation Medicine positions in Q3 2013 and 0 closed out, a net change of +17 holders.
- The largest Foundation Medicine buyer in Q3 2013 was Citadel Advisors, an estimated $19.5M added.
Based on aggregated 13F filings for Q3 2013.